A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy

NCT02245334 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1578

Last updated 2014-09-22

No results posted yet for this study

Summary

To assess the effect of povidone-iodine on infectious complication rate caused by transrectal prostate biopsy

Conditions

  • Infection
  • Prostatic Diseases
  • Misadventure During Aspirating Needle Biopsy

Interventions

DRUG

Povidone-Iodine

1 pill per biopsy

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Sangchul Lee, MD.PhD. · Prof

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-10-31
Completion
2015-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02245334 on ClinicalTrials.gov